Aptevo Therapeutics (APVO) Divestments (2017 - 2020)
Aptevo Therapeutics (APVO) posted Divestments of $28.1 million for Q1 2020, up 43161.54% sequentially from $65000.0 in Q3 2018.
Aptevo Therapeutics (APVO) Divestments (2017 - 2020) Analysis & Trends
Aptevo Therapeutics has reported Divestments for 3 years, with the latest figure at $28.1 million in Q1 2020.
- Quarterly Divestments changed N/A year-over-year to $28.1 million in Q1 2020, while the trailing twelve-month figure through Dec 2020 was $28.1 million (up 15182.61% YoY) and the FY2020 annual result came in at $28.1 million, up 561.65% from the prior year.
- Divestments grew to $28.1 million in Q1 2020 per APVO's latest filing, from $65000.0 in the prior quarter.
- Over five years, Divestments peaked at $28.1 million in Q1 2020 and troughed at -$714000.0 in Q4 2017.
- A 3-year average of $5.5 million and a median of $65000.0 in 2018 frame the typical range for Divestments.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -13.21 Mn |
| 10 | Aptevo Therapeutics | 3.18 Mn | -6.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 28.12 Mn |
| Sep 30, 2018 | 65,000.00 |
| Jun 30, 2018 | 65,000.00 |
| Mar 31, 2018 | 54,000.00 |
| Dec 31, 2017 | -714,000.00 |